INDIANAPOLIS, Dec. 19, 2017 (GLOBE NEWSWIRE) -- PTS Diagnostics, a U.S.–based manufacturer of point-of-care biometric testing devices, today announced that they are releasing PTS Connect TM ScreenPro, ...

WHITESTOWN, Ind. (Inside INdiana Business) — Whitestown-based PTS Diagnostics has selected Jonathan Chapman as president and chief executive officer. Chapman most recently served as president or ...

Key strategic alliance for both companies as they work to close gaps in care for patients with chronic diseases around the world. “Our collaboration with PTS Diagnostics has greatly contributed to ...

PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, announces the launch of the PTS Connect Wellness Solution. This ...

PTS Diagnostics is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets ...

An Indianapolis-based company that makes handheld medical-testing devices for cholesterol and blood sugar has agreed to be sold to a Chinese company in a deal that could be worth $200 million. PTS ...

PTS Diagnostics was in poor shape when Obamacare passed nearly five years ago. The Indianapolis-based maker of CardioChek blood testing devices had spent the previous four years trying to catch ...

The PTS Connect™ universal solution is a portable, lightweight tool that connects up to 15 different biometric devices via USB, Wi-Fi ® and any next generation technology even when an Internet ...

INDIANAPOLIS, Jan. 25, 2019 /PRNewswire-PRWeb/ -- PTS Diagnostics, a U.S.-based manufacturer of point-of-care testing devices announced today that the U.S. Food and Drug Administration (FDA) has ...

WHITESTOWN, Ind., October 08, 2025--(BUSINESS WIRE)--PTS Diagnostics, Inc., a manufacturer of high-quality point-of-care diabetes-related blood testing devices, is announcing the planned closure of ...

China's Sinocare is grabbing U.S. diagnostics player PTS Diagnostics in a deal valued at $200 million. The move is meant to help Sinocare expand its global footprint and get its hands on the company's ...